1887

Abstract

This study aimed to correlate the multidrug resistance (MDR) and sequence type (ST) clones of community-associated (CA) meticillin-resistant (MRSA) to identify the genes responsible for clindamycin and mupirocin resistance in isolates from paediatric hospitals in mainland China. A total of 435 isolates were collected. Compared with CA meticillin-susceptible (MSSA), the resistance rates of CA-MRSA to ciprofloxacin, chloramphenicol, gentamicin and tetracycline were higher (19.0 vs 2.6 %, <0.001; 14.7 vs 3.1 %, <0.001; 14.7 vs 3.1 %, <0.01; and 46.0 vs 13.3 %, <0.001, respectively). Compared with hospital-associated (HA)-MRSA, the resistance rates of CA-MRSA to ciprofloxacin, gentamicin, rifampicin, tetracycline and trimethoprim–sulfamethoxazole were lower (19 vs 94.8 %, <0.001; 14.7 vs 84.4 %, <0.001; 5.5 vs 88.3 %, <0.001; 46 vs 94.8 %, <0.001; and 1.8 vs 9.1 %, <0.01, respectively). The resistance rates of CA-MRSA, HA-MRSA and CA-MSSA to clindamycin (92.0, 77.9 and 64.1 %, respectively) and erythromycin (85.9, 77.9 and 63.1 %, respectively) were high. The MDR rates (resistance to three or more non-β-lactams) were 49.6, 100 and 14 % in the CA-MRSA, HA-MRSA and CA-MSSA isolates, respectively. Five of seven ST clones in the CA-MRSA isolates, namely ST59, ST338, ST45, ST910 and ST965, had MDR rates of >50 % (67.9, 87.5, 100, 50 and 83.3 %, respectively). The constitutive phenotype of macrolide–lincosamide–streptogramin B (MLS) resistance (69 %) and the gene (38.1 %) predominated among the MLS-resistant CA strains. The resistance rate to mupirocin was 2.3 % and plasmids carrying the gene varied in size between 23 and 54.2 kb in six strains with high-level resistance as determined by Southern blot analysis. The present study showed that resistance to non-β-lactams, especially to clindamycin, is high in CA-MRSA isolates from Chinese children and that the profile of resistance is related to clonal type. This study revealed distinctive patterns of MLS-resistant genes among CA isolates.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.042663-0
2012-09-01
2020-07-07
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/9/1240.html?itemId=/content/journal/jmm/10.1099/jmm.0.042663-0&mimeType=html&fmt=ahah

References

  1. Bannerman T. L., Hancock G. A., Tenover F. C., Miller J. M. 1995; Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus . J Clin Microbiol 33:551–555[PubMed]
    [Google Scholar]
  2. Carleton H. A., Diep B. A., Charlebois E. D., Sensabaugh G. F., Perdreau-Remington F. 2004; Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 190:1730–1738 [CrossRef][PubMed]
    [Google Scholar]
  3. Chen C.-J., Hsueh P.-R., Su L.-H., Chiu C.-H., Lin T.-Y., Huang Y.-C. 2009; Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan. Diagn Microbiol Infect Dis 65:199–201 [CrossRef][PubMed]
    [Google Scholar]
  4. Chen W.-T., Wang J.-T., Lee W.-S., Huang C.-H., Liao C.-H., Chen Y.-C., Chang S.-C. 2010; Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay for detecting MRSA nasal colonization in Taiwanese adults. J Microbiol Immunol Infect 43:372–377 [CrossRef][PubMed]
    [Google Scholar]
  5. CLSI 2010 Performance Standards for Antimicrobial Susceptibility Testing, 20th Informational Supplement M100–S20 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  6. David M. Z., Crawford S. E., Boyle-Vavra S., Hostetler M. A., Kim D. C., Daum R. S. 2006; Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis 12:631–637 [CrossRef][PubMed]
    [Google Scholar]
  7. De Angelis G., Cipriani M., Cauda R., Tacconelli E. 2011; Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole. Clin Infect Dis 52:1471–1472, author reply 1472 [CrossRef][PubMed]
    [Google Scholar]
  8. Enright M. C., Day N. P., Davies C. E., Peacock S. J., Spratt B. G. 2000; Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus . J Clin Microbiol 38:1008–1015[PubMed]
    [Google Scholar]
  9. Fridkin S. K., Hageman J. C., Morrison M., Sanza L. T., Como-Sabetti K., Jernigan J. A., Harriman K., Harrison L. H., Lynfield R., Farley M. M. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network 2005; Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436–1444 [CrossRef][PubMed]
    [Google Scholar]
  10. Geng W., Yang Y., Wang C., Deng L., Zheng Y., Shen X. 2010a; Skin and soft tissue infections caused by community-associated methicillin-resistant Staphylococcus aureus among children in China. Acta Paediatr 99:575–580 [CrossRef][PubMed]
    [Google Scholar]
  11. Geng W., Yang Y., Wu D., Huang G., Wang C., Deng L., Zheng Y., Fu Z., Li C. et al. 2010b; Molecular characteristics of community-acquired, methicillin-resistant Staphylococcus aureus isolated from Chinese children. FEMS Immunol Med Microbiol 58:356–362[PubMed]
    [Google Scholar]
  12. Goering V., Winters M. A. 1992; Rapid method for epidemiological evaluation of Gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol 6:491–502
    [Google Scholar]
  13. Grundmann H., Aires-de-Sousa M., Boyce J., Tiemersma E. 2006; Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874–885 [CrossRef][PubMed]
    [Google Scholar]
  14. Herold B. C., Immergluck L. C., Maranan M. C., Lauderdale D. S., Gaskin R. E., Boyle-Vavra S., Leitch C. D., Daum R. S. 1998; Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593–598 [CrossRef][PubMed]
    [Google Scholar]
  15. Ho P. L., Lai E. L., Chan M. Y., Chow K. H. 2011; Distinctive patterns of macrolide–lincosamide–streptogramin resistance phenotypes and determinants amongst Staphylococcus aureus populations in Hong Kong. Int J Antimicrob Agents 37:181–182 [CrossRef][PubMed]
    [Google Scholar]
  16. Hultén K. G., Kaplan S. L., Gonzalez B. E., Hammerman W. A., Lamberth L. B., Versalovic J., Mason E. O. Jr 2006; Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J 25:349–353 [CrossRef][PubMed]
    [Google Scholar]
  17. Khan S. A., Novick R. P. 1980; Terminal nucleotide sequences of Tn551, a transposon specifying erythromycin resistance in Staphylococcus aureus: homology with Tn3 . Plasmid 4:148–154 [CrossRef][PubMed]
    [Google Scholar]
  18. Klevens R. M., Morrison M. A., Nadle J., Petit S., Gershman K., Ray S., Harrison L. H., Lynfield R., Dumyati G. et al. 2007; Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771 [CrossRef][PubMed]
    [Google Scholar]
  19. Liu Q.-Z., Wu Q., Zhang Y.-B., Liu M.-N., Hu F.-P., Xu X.-G., Zhu D.-M., Ni Y.-X. 2010; Prevalence of clinical meticillin-resistant Staphylococcus aureus (MRSA) with high-level mupirocin resistance in Shanghai and Wenzhou, China. Int J Antimicrob Agents 35:114–118 [CrossRef][PubMed]
    [Google Scholar]
  20. Liu C., Bayer A., Cosgrove S. E., Daum R. S., Fridkin S. K., Gorwitz R. J., Kaplan S. L., Karchmer A. W., Levine D. P. et al. 2011; Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18–e55 [CrossRef][PubMed]
    [Google Scholar]
  21. Lo W.-T., Wang C.-C., Lin W.-J., Wang S.-R., Teng C.-S., Huang C.-F., Chen S.-J. 2010; Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004–2009. PLoS ONE 5:e15791 [CrossRef]
    [Google Scholar]
  22. Moore C. L., Osaki-Kiyan P., Perri M., Donabedian S., Haque N. Z., Chen A., Zervos M. J. 2010; USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit. J Clin Microbiol 48:2307–2310 [CrossRef][PubMed]
    [Google Scholar]
  23. Otsuka T., Zaraket H., Takano T., Saito K., Dohmae S., Higuchi W., Yamamoto T. 2007; Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan. Clin Microbiol Infect 13:325–327 [CrossRef][PubMed]
    [Google Scholar]
  24. Otter J. A., French G. L. 2008; The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006. Clin Microbiol Infect 14:670–676 [CrossRef]
    [Google Scholar]
  25. Otter J. A., French G. L. 2010; Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 10:227–239 [CrossRef][PubMed]
    [Google Scholar]
  26. Pan E. S., Diep B. A., Carleton H. A., Charlebois E. D., Sensabaugh G. F., Haller B. L., Remington F. P. 2003; Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 37:1384–1388 [CrossRef][PubMed]
    [Google Scholar]
  27. Ruhe J. J., Menon A. 2007; Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 51:3298–3303 [CrossRef][PubMed]
    [Google Scholar]
  28. Song J.-H., Hsueh P.-R., Chung D. R., Ko K. S., Kang C.-I., Peck K. R., Yeom J.-S., Kim S.-W., Chang H.-H. et al. 2011; Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother 66:1061–1069 [CrossRef][PubMed]
    [Google Scholar]
  29. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. 1996; Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562–2566[PubMed]
    [Google Scholar]
  30. Waites K. B., Duffy L. B., Dowzicky M. J. 2006; Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother 50:3479–3484 [CrossRef][PubMed]
    [Google Scholar]
  31. Wang H., Liu Y., Sun H., Xu Y., Xie X., Chen M. 2008; In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China. Diagn Microbiol Infect Dis 62:226–229 [CrossRef][PubMed]
    [Google Scholar]
  32. Whitby C. R., Kaplan S. L., Mason E. O. Jr, Carrillo-Marquez M., Lamberth L. B., Hammerman W. A., Hultén K. G. 2011; Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol 75:118–121 [CrossRef][PubMed]
    [Google Scholar]
  33. Wu D., Wang Q., Yang Y., Geng W., Wang Q., Yu S., Yao K., Yuan L., Shen X. 2010; Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children’s hospital in Beijing, China. Diagn Microbiol Infect Dis 67:1–8 [CrossRef][PubMed]
    [Google Scholar]
  34. Yoon E.-J., Kwon A.-R., Min Y.-H., Choi E.-C. 2008; Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B. J Antimicrob Chemother 61:533–540 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.042663-0
Loading
/content/journal/jmm/10.1099/jmm.0.042663-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error